Ascendiant Capital Markets Forecasts Synergy CHC Q3 Earnings

Synergy CHC Corp. (NASDAQ:SNYR) – Equities research analysts at Ascendiant Capital Markets decreased their Q3 2026 earnings estimates for shares of Synergy CHC in a research note issued on Tuesday, June 9th. Ascendiant Capital Markets analyst E. Woo now expects that the company will earn $0.01 per share for the quarter, down from their prior estimate of $0.05. Ascendiant Capital Markets has a “Buy” rating and a $5.50 price target on the stock. The consensus estimate for Synergy CHC’s current full-year earnings is $0.13 per share. Ascendiant Capital Markets also issued estimates for Synergy CHC’s Q4 2026 earnings at ($0.01) EPS, Q1 2027 earnings at $0.01 EPS, Q2 2027 earnings at $0.04 EPS, Q3 2027 earnings at $0.05 EPS and FY2027 earnings at $0.15 EPS.

Separately, Weiss Ratings lowered shares of Synergy CHC from a “hold (c-)” rating to a “sell (d-)” rating in a report on Friday, April 10th. Two investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $6.25.

Synergy CHC Price Performance

Shares of SNYR stock opened at $0.20 on Friday. The firm has a market cap of $3.05 million, a P/E ratio of -0.14 and a beta of -0.27. Synergy CHC has a 1-year low of $0.19 and a 1-year high of $4.00. The firm’s 50-day simple moving average is $0.40 and its 200-day simple moving average is $1.23.

Synergy CHC (NASDAQ:SNYR) last posted its earnings results on Thursday, May 14th. The company reported ($0.23) earnings per share for the quarter, missing the consensus estimate of $0.03 by ($0.26). Synergy CHC had a negative net margin of 60.02% and a negative return on equity of 19.51%. The business had revenue of $5.49 million for the quarter.

Hedge Funds Weigh In On Synergy CHC

Several institutional investors and hedge funds have recently bought and sold shares of the business. Geode Capital Management LLC grew its stake in Synergy CHC by 29.9% during the 4th quarter. Geode Capital Management LLC now owns 36,038 shares of the company’s stock valued at $67,000 after acquiring an additional 8,288 shares in the last quarter. Virtu Financial LLC purchased a new position in Synergy CHC during the 3rd quarter valued at about $38,000. DRW Securities LLC purchased a new position in Synergy CHC during the 4th quarter valued at about $36,000. XTX Topco Ltd purchased a new position in Synergy CHC during the 2nd quarter valued at about $57,000. Finally, Heartland Advisors Inc. purchased a new position in Synergy CHC during the 3rd quarter valued at about $1,342,000.

Synergy CHC Company Profile

Synergy CHC Corp. engages in the marketing and distribution of branded health and wellness products. The company was founded on December 29, 2010 and is headquartered in Westbrook, ME.